P/B
1,6
iSpecimen
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
$2.7M
Market Cap • 10/2/2026
2009
(17 years)
Founded
2021
(5 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
5,8
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
0,7
EPS
—
Market Cap
Market Cap
2,7M
EV
-1,5M
EV/Revenue
-3,2
EV/EBITDA
0,2
EV/EBIT
0,2
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-156,2%
Total Yield
-156,2%
Payout
0%
Retained Earnings
-86M
Profitability
Gross Margin
—
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
0%
Capex/Revenue
0%
Capex/D&A
0%
Capex/OCF
0%
SBC/OCF
—
% PPE
3,5%
% Goodwill
0%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
-46,7%
CAGR Op. Income 5Y
17,9%
CAGR Net Income 5Y
9,8%
CAGR OCF 5Y
14,2%
Leverage
N.D./EBITDA
0,5
Debt/Equity
0%
Current Ratio
0
Quick Ratio
0
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!